PLIANT THERAPEUTICS, INC.PLRXEarnings & Financial Report
Nasdaq
PLRX Q4 2024 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-53.3M
Net Profit
$-49.7M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.82
PLIANT THERAPEUTICS, INC. Q4 2024 Financial Summary
PLIANT THERAPEUTICS, INC. reported revenue of $0 for Q4 2024, with a net profit of $-49.7M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-49.7M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q4 2024 |
PLIANT THERAPEUTICS, INC. Annual Revenue by Year
PLIANT THERAPEUTICS, INC. annual revenue history includes year-by-year totals (for example, 2024 revenue was $0).
| Year | Annual Revenue |
|---|---|
| 2024 | $0 |
| 2023 | $1.6M |
| 2022 | $9.7M |
Income Statement
| Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3M | $248000 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | 6.6% | -95.0% | N/A | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $597.9M | $574.9M | $540.5M | $512.2M | $521.6M | $483.7M | $445.7M | $396.9M |
| Liabilities | $36.0M | $41.8M | $37.4M | $38.6M | $84.3M | $91.1M | $99.8M | $92.9M |
| Equity | $561.9M | $533.1M | $503.0M | $473.6M | $437.3M | $392.7M | $345.8M | $304.1M |
Cash Flow
| Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-30.3M | $-24.8M | $-36.2M | $-25.1M | $-30.3M | $-45.3M | $-32.3M | $-47.7M |